Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Inflammatory blood count ratios discriminate disease activity and remain persistently elevated during glucocorticoid-free remission in ANCA-associated vasculitis.

Clinical and experimental medicine·2026
Same author

A model to increase automation and support reliable interpretation of clinical chemistry tests.

Clinical chemistry and laboratory medicine·2026
Same author

Thyroglobulin as a proxy for iodine status in pregnancy.

The British journal of nutrition·2026
Same author

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.

International journal of cancer·2026
Same author

Correction: Ketogenic diet improves disease activity and cardiovascular risk in psoriatic arthritis: A proof of concept study.

PloS one·2026
Same author

RSV Detection and Antibiotic Prescribing Decisions for Pediatric Respiratory Tract Infections.

JAMA network open·2026

相关实验视频

Updated: Jun 16, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.1K

血脂的儿科参考间隔:间接估计使用一个大规模的14年数据库.

Paola Galozzi1, Andrea Padoan1, Carlo Moretti2

  • 1Laboratory Medicine Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.

Journal of pediatric gastroenterology and nutrition
|April 12, 2024
PubMed
概括
此摘要是机器生成的。

对于儿童来说,建立特定于人群的脂质参考区间 (RIs) 是至关重要的. 这项研究使用数据挖掘来创建儿科胆固醇和甘油三的间接RI,为改善实验室服务提供实用,低成本的解决方案.

关键词:
胆固醇 胆固醇 胆固醇 是一种间接参考区间 (RIs) 是指一个间接的参考区间.儿科 儿科 儿科三甲酸甘油三甲酸甘油三甲酸甘油

更多相关视频

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

8.8K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K

相关实验视频

Last Updated: Jun 16, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.1K
Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

8.8K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K

科学领域:

  • 临床化学 临床化学
  • 儿科实验室医学 儿科实验室医学
  • 生物统计学 生物统计学

背景情况:

  • 对于儿科患者来说,建立直接参考间隔 (RIs) 是一个挑战.
  • 间接的RI提供了使用现有临床数据的实用,低成本的替代方案.
  • 脱脂症是儿童群体的一个重大问题.

研究的目的:

  • 为儿科患者建立特定人群的脂质参考间隔 (RIs).
  • 为当地儿童提供增强的实验室服务.
  • 为了利用数据挖掘来间接确定RI.

主要方法:

  • 对18岁以下患者 (2009-2022) 的实验室数据 (胆固醇,甘油三,LDL,HDL) 的回顾性分析.
  • 在RI估计中应用RefineR算法.
  • 使用排除标准对数据进行了精细化,结果有17933个患者记录.

主要成果:

  • 针对儿科脂质分析物的特定人群的RI被确定.
  • 年龄和性别分层显示出差异,特别是在5岁以下儿童的TC和TG中.
  • 已确定的RI值与文献值相比较,儿童<3岁的TG上限明显较低.

结论:

  • 衍生的儿科脂质RI是根据特定患者群体量身定制的.
  • 这些RI对于准确的儿科脂质监测至关重要.
  • 间接RI建立是儿科实验室服务的一个有价值的方法.